Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Jalencas

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular Informatics|August 3, 2016
Identification of Similar Binding Sites to Detect Distant PolypharmacologyXavier Jalencas, Jordi Mestres
Journal of Chemical Information and Modeling|January 15, 2013
Chemoisosterism in the proteomeXavier Jalencas, Jordi Mestres
Journal of Chemical Information and Modeling|April 16, 2026
SAFR: Enabling Fragment-Based Drug Discovery with a Synthetic Binding Pose Data SetJoan Cabot-March, Xavier Jalencas, Jordi Mestres
Drug Discovery Today|June 22, 2019
The human endogenous metabolome as a pharmacology baseline for drug discoveryAndreu Bofill, Xavier Jalencas, Tudor I Oprea, et al.
ACS Chemical Biology|October 3, 2012
Identification of pim kinases as novel targets for PJ34 with confounding effects in PARP biologyAlbert A Antolín, Xavier Jalencas, José Yélamos, et al.
Scientific Reports|November 17, 2022
Fragment-based virtual screening identifies a first-in-class preclinical drug candidate for Huntington's diseaseSimon Marius Galyan, Collin Y Ewald, Xavier Jalencas, et al.
RSC Medicinal Chemistry|April 26, 2024
Design, quality and validation of the EU-OPENSCREEN fragment library poised to a high-throughput screening collectionXavier Jalencas, Hannes Berg, Ludvik Olai Espeland, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Informatics|August 3, 2016
Identification of Similar Binding Sites to Detect Distant PolypharmacologyXavier Jalencas, Jordi Mestres
Journal of Chemical Information and Modeling|January 15, 2013
Chemoisosterism in the proteomeXavier Jalencas, Jordi Mestres
Journal of Chemical Information and Modeling|April 16, 2026
SAFR: Enabling Fragment-Based Drug Discovery with a Synthetic Binding Pose Data SetJoan Cabot-March, Xavier Jalencas, Jordi Mestres
Drug Discovery Today|June 22, 2019
The human endogenous metabolome as a pharmacology baseline for drug discoveryAndreu Bofill, Xavier Jalencas, Tudor I Oprea, et al.
ACS Chemical Biology|October 3, 2012
Identification of pim kinases as novel targets for PJ34 with confounding effects in PARP biologyAlbert A Antolín, Xavier Jalencas, José Yélamos, et al.
Scientific Reports|November 17, 2022
Fragment-based virtual screening identifies a first-in-class preclinical drug candidate for Huntington's diseaseSimon Marius Galyan, Collin Y Ewald, Xavier Jalencas, et al.
RSC Medicinal Chemistry|April 26, 2024
Design, quality and validation of the EU-OPENSCREEN fragment library poised to a high-throughput screening collectionXavier Jalencas, Hannes Berg, Ludvik Olai Espeland, et al.
Pageof 1